BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35720343)

  • 1. Decoy Receptor 3 Suppresses T-Cell Priming and Promotes Apoptosis of Effector T-Cells in Acute Cell-Mediated Rejection: The Role of Reverse Signaling.
    Weng SC; Wen MC; Hsieh SL; Chen NJ; Tarng DC
    Front Immunol; 2022; 13():879648. PubMed ID: 35720343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.
    Hsieh SL; Lin WW
    J Biomed Sci; 2017 Jun; 24(1):39. PubMed ID: 28629361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3).
    You RI; Chang YC; Chen PM; Wang WS; Hsu TL; Yang CY; Lee CT; Hsieh SL
    Blood; 2008 Feb; 111(3):1480-8. PubMed ID: 18006694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of prognostic biomarker decoy receptor 3 and immunomodulation in kidney diseases.
    Weng SC; Tarng DC
    J Chin Med Assoc; 2019 Sep; 82(9):680-684. PubMed ID: 31356560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoy receptor 3 suppresses TLR2-mediated B cell activation by targeting NF-κB.
    Huang ZM; Kang JK; Chen CY; Tseng TH; Chang CW; Chang YC; Tai SK; Hsieh SL; Leu CM
    J Immunol; 2012 Jun; 188(12):5867-76. PubMed ID: 22581854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication.
    Wu SF; Liu TM; Lin YC; Sytwu HK; Juan HF; Chen ST; Shen KL; Hsi SC; Hsieh SL
    J Leukoc Biol; 2004 Feb; 75(2):293-306. PubMed ID: 14634066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
    Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
    Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.
    Lin WW; Hsieh SL
    Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid.
    Mueller AM; Pedré X; Killian S; David M; Steinbrecher A
    J Neuroimmunol; 2009 Apr; 209(1-2):57-64. PubMed ID: 19269042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of Th1 response in decoy receptor 3 transgenic mice.
    Hsu TL; Wu YY; Chang YC; Yang CY; Lai MZ; Su WB; Hsieh SL
    J Immunol; 2005 Oct; 175(8):5135-45. PubMed ID: 16210617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoy receptor 3 protects non-obese diabetic mice from autoimmune diabetes by regulating dendritic cell maturation and function.
    Wang YL; Chou FC; Sung HH; Fan PL; Hsueh CW; Lin WC; Chen SJ; Lin WW; Sytwu HK
    Mol Immunol; 2010 Oct; 47(16):2552-62. PubMed ID: 20801512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules.
    Choi YJ; Baranowska-Daca E; Nguyen V; Koji T; Ballantyne CM; Sheikh-Hamad D; Suki WN; Truong LD
    Kidney Int; 2000 Oct; 58(4):1481-91. PubMed ID: 11012883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoy Receptor 3 Inhibits Monosodium Urate-Induced NLRP3 Inflammasome Activation
    Pan YG; Huang MT; Sekar P; Huang DY; Lin WW; Hsieh SL
    Front Immunol; 2021; 12():638676. PubMed ID: 33746978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoy receptor 3 suppresses FasL-induced apoptosis via ERK1/2 activation in pancreatic cancer cells.
    Zhang Y; Li D; Zhao X; Song S; Zhang L; Zhu D; Wang Z; Chen X; Zhou J
    Biochem Biophys Res Commun; 2015 Aug; 463(4):1144-51. PubMed ID: 26102031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo.
    Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D
    Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoy Receptor 3 Improves Survival in Experimental Sepsis by Suppressing the Inflammatory Response and Lymphocyte Apoptosis.
    Liang D; Hou Y; Lou X; Chen H
    PLoS One; 2015; 10(6):e0131680. PubMed ID: 26121476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis.
    Harper N; Hughes M; MacFarlane M; Cohen GM
    J Biol Chem; 2003 Jul; 278(28):25534-41. PubMed ID: 12721308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DcR3 induces cell proliferation through MAPK signaling in chondrocytes of osteoarthritis.
    Hayashi S; Nishiyama T; Miura Y; Fujishiro T; Kanzaki N; Hashimoto S; Matsumoto T; Kurosaka M; Kuroda R
    Osteoarthritis Cartilage; 2011 Jul; 19(7):903-10. PubMed ID: 21420502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts.
    Fukuda K; Miura Y; Maeda T; Takahashi M; Hayashi S; Kurosaka M
    Int J Mol Med; 2013 Oct; 32(4):910-6. PubMed ID: 23912906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.
    Im J; Kim K; Hergert P; Nho RS
    J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.